Prognostic factors of hematological recovery in life-threatening nonchemotherapy drug-induced agranulocytosis -: A study of 91 patients from a single center

被引:17
作者
Maloisel, F [1 ]
Andrès, E [1 ]
Kaltenbach, G [1 ]
Noel, E [1 ]
Martin-Hunyadi, C [1 ]
Dufour, P [1 ]
机构
[1] Hop Univ Strasbourg, Clin Med B, Serv Med Interne Diabet & Malad Metabol, F-67091 Strasbourg, France
来源
PRESSE MEDICALE | 2004年 / 33卷 / 17期
关键词
D O I
10.1016/S0755-4982(04)98884-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives We studied clinical factors that may influence the duration of hematological recovery to reach neutrophil counts and thus, indirectly, the prognosis in patients with life-threatening drug-induced agranulocytosis (DIA). Methods Using univariate and multivariate analyses with Cox's proportional hazard models, we determined the prognostic factors for hematological recovery defined as neutrophil counts > 05 and > 1.5.10(9)/L, in 91 patients with established life-threatening DIA. Results Multivariable analysis showed that neutrophil count < 0.1.10(9)/L (at diagnosis) and infection profile: severe infections or septic shock, adversely influenced the neutrophil recovery (for the two neutrophil levels). Hematopoietic growth factors were significantly associated with rapid hematological recovery (for the two neutrophil levels). Documented microbial infections and antiplatelet DIA were also associated with rapid hematological recovery (for a neutrophil count > 15.10(9)/L). Conclusion Our findings demonstrate that in life-threatening DIA, hematological recovery is mainly dependant of the neutrophil level, the type of infections and the utilization of hematopoietic growth factors.
引用
收藏
页码:1164 / 1168
页数:5
相关论文
共 23 条
  • [1] Nonchemotherapy drug-induced agranulocytosis:: interest of haematopoietic growth factors
    Andrès, E
    Noel, E
    Maloisel, F
    [J]. JOURNAL OF INTERNAL MEDICINE, 2002, 251 (06) : 533 - 534
  • [2] Nonchemotherapy drug-induced agranulocytosis in elderly patients:: The effects of granulocyte colony-stimulating factor
    Andrès, E
    Kurtz, JE
    Martin-Hunyadi, C
    Kaltenbach, G
    Alt, M
    Weber, JC
    Sibilia, J
    Schlienger, JL
    Dufour, P
    Maloisel, F
    [J]. AMERICAN JOURNAL OF MEDICINE, 2002, 112 (06) : 460 - 464
  • [3] Nonchemotherapy drug-induced agranulocytosis:: experience of the Strasbourg teaching hospital (1985-2000) and review of the literature
    Andrès, E
    Kurtz, JE
    Maloisel, F
    [J]. CLINICAL AND LABORATORY HAEMATOLOGY, 2002, 24 (02): : 99 - 106
  • [4] Haematopoietic growth factor in antithyroid-drug-induced agranulocytosis
    Andrès, E
    Kurtz, JE
    Perrin, AE
    Dufour, P
    Schlienger, JL
    Maloisel, F
    [J]. QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 2001, 94 (08): : 423 - 428
  • [5] Andres E, 1998, SEM HOP PARIS, V74, P1105
  • [6] Are hematopoietic growth factors useful in the management of drug-induced agranulocytosis?
    Andrès, E
    Maloisel, F
    Kurtz, JE
    Vinzio, S
    Sibilia, J
    Schlienger, JL
    Dufour, P
    [J]. REVUE DE MEDECINE INTERNE, 2000, 21 (07): : 580 - 585
  • [7] Nonchemotherapy drug-induced agranulocytosis: A review of 118 patients treated with colony-stimulating factors
    Beauchesne, MF
    Shalansky, SJ
    [J]. PHARMACOTHERAPY, 1999, 19 (03): : 299 - 305
  • [8] Benichou C, 1993, NOUV REV FR HEMATOL, V33, P257
  • [9] Collett D, 2014, MODELLING SURVIVAL D
  • [10] DALE DC, 1990, HEMATOLOGY, P812